Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05IIP
|
|||
| Former ID |
DIB000295
|
|||
| Drug Name |
L-651582
|
|||
| Synonyms |
Carboxyamidotriazole (CAI)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 3 | [1] | |
| Company |
National Cancer Institute
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H12Cl3N5O2
|
|||
| Canonical SMILES |
C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2Cl)CN3C(=C(N=N3)C(=O)N)N)Cl)Cl
|
|||
| InChI |
1S/C17H12Cl3N5O2/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25/h1-6H,7,21H2,(H2,22,27)
|
|||
| InChIKey |
WNRZHQBJSXRYJK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 99519-84-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
485747, 639419, 4254373, 6887112, 8141938, 10234614, 10320678, 11409172, 11459118, 11461236, 12013671, 14831891, 26653376, 44437032, 50065444, 50109733, 57338464, 58108226, 80545111, 92722332, 103143867, 103310486, 104380609, 117565421, 123122707, 124635539, 124753387, 124878929, 125569773, 126627359, 126648997, 126662661, 129607850, 134224803, 135064836, 135698191, 137038061, 140115329, 143493287, 152243201, 162202203, 162220752, 162755062, 164038435, 164849207, 171578519, 174006266, 196107484, 198972622, 198991783
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Muscarinic acetylcholine receptor M5 (CHRM5) | Target Info | Modulator | [1] |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Cholinergic synapse | ||||
| Regulation of actin cytoskeleton | ||||
| Panther Pathway | Alzheimer disease-amyloid secretase pathway | |||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
| Reactome | Muscarinic acetylcholine receptors | |||
| G alpha (q) signalling events | ||||
| WikiPathways | Monoamine GPCRs | |||
| Calcium Regulation in the Cardiac Cell | ||||
| Regulation of Actin Cytoskeleton | ||||
| GPCRs, Class A Rhodopsin-like | ||||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J Pharmacol Exp Ther. 1991 Jun;257(3):967-71. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.